Article
Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC
2022-10-14
Abstract excerpt
Lung cancer is one of the most prevalent malignant tumors worldwide, with lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) accounting for the majority of cases. Cuproptosis, tumor immune microenvironment (TIME) and long non-coding RNA (lncRNA) have been demonstrated to be associated with tumorigenesis. The objective of the present study was to develop a novel cuproptosis-related lncRNA signature...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- da9551dc-e03e-54b2-843a-354b8bd019ff
- DOI
- 10.21203/rs.3.rs-2146552/v1
